Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study

Objectives To assess incidence, severity and predictors of COVID-19, including protective post-vaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike protein (anti-RBD), informing further vaccine strategies for patients with immune-mediated inflammatory diseases (IMIDs)...

Descripción completa

Detalles Bibliográficos

Autores principales:	Tore K Kvien, Joseph Sexton, Espen A Haavardsholm, Sella A Provan, Jorgen Jahnsen, Silje Watterdal Syversen, Guro Løvik Goll, Ingrid Jyssum, Siri Mjaaland, Ludvig A Munthe, Gunnveig Grødeland, Kristin Kaasen Jørgensen, Hilde S Ørbo, Kristin H Bjørlykke, Anne T Tveter, Ingrid E Christensen, Grete B Kro, John T Vaage
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 2024-05-01
Colección:	RMD Open
Acceso en línea:	https://rmdopen.bmj.com/content/10/2/e003545.full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!